Disclosure of Unlabeled Use and Investigational Product
Expiration Date: August 3, 2024
This session, which was included as part of the 2023 Ophthalmology 360 Summit Series, will review nonsurgical and surgical strategies for correcting presbyopia, from glasses and contact lenses to eye drops and procedures, including use of intraocular lenses and emerging techniques such as laser scleral microporation. Discussion will focus on how patients can be better matched with treatments.
This activity is designed for an audience of ophthalmologists, optometrists, and other members of the healthcare team who treat patients with presbyopia.
Upon completion of the educational activity, participants should be able to:
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at
ketrea@akhcme.com
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.00
AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AKH Inc., Advancing Knowledge in Healthcare designates this asynchronous activity for a maximum of 1.0 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by independent educational grants from Alcon, Genentech, Regenxbio, Tarsus, Théa, and Visus.
Name
Relationship
Commercial Interest
Session Faculty
Cathleen McCabe, MD (moderator)
Advisor, Consultant
Abbvie
Advisor, Consultant, Speaker
Alcon
Advisor, Consultant, Speaker
Allergan
Advisor, Consultant, Speaker
Bausch + Lomb
Advisor, Consultant, Speaker
Carl Zeiss
Advisor, Consultant
Dompe
Consultant
Easee
Advisor, Consultant, Stock
EngageTechnologies
Advisor, Consultant, Speaker
EyePoint
Speaker
Glaukos
Advisor, Consultant
ImprimisRx
Advisor, Consultant
ISTAR Medical
Advisor, Consultant, Speaker
Ivantis
Speaker
Lensar
Advisor, Consultant, Speaker
Novartis
Advisor, Consultant, Speaker
Ocular Therapeutix
Advisor, Consultant
Ocuphire
Advisor, Consultant, Speaker
Omeros
Advisor, Consultant
Orasis
Advisor, Consultant
Quidel EyeHealth
Speaker
RX Sight
Advisor, Consultant
Science Based Health
Advisor, Consultant, Speaker
Sight Sciences
Advisor, Consultant
Sun Ophthalmics
Advisor
SpyGlass
Speaker
Tarsus Pharmaceuticals
Advisor, Consultant
Visus Therapeutics
Jennifer Loh, MD (faculty)
Advisor, Consultant, Speaker
Alcon
Advisor, Consultant
Allergan
Advisor, Consultant, Speaker
Bausch + Lomb
Advisor, Consultant
Johnson & Johnson
Advisor, Consultant
LensAr
Advisor, Consultant
Novartis
Advisor, Consultant
Novabay
Advisor, Consultant
Ocular Science
Advisor, Consultant
Orasis
Advisor, Consultant, Research, Speaker
Sight Sciences
Advisor, Consultant, Speaker
Sun Ophthalmics
Advisor, Consultant
Tarsus
Advisor, Consultant
Visus
Advisor, Consultant
Zeiss
Maria Sampalis, OD (faculty)
Consultant
Tarsus
Consultant
Allergan
Consultant
Zeiss
Dorothy Caputo, MA, BSN, RN, VP, Healthcare Continuing Education & Operations
N/A
Nothing to disclose
Michele Bielarski, RN (planner/reviewer)
N/A
Nothing to disclose
AKH Inc. Staff and Planners
N/A
Nothing to disclose
International Healthcare Media, LLC Staff and Planners
N/A
Nothing to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.
Putting Presbyopia Correction Strategies Into Focus
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.